Danilo D'Alessandro - 21 Nov 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Chief Financial Officer
Issuer ticker: CLPT
Reported as of: 21 Nov 2025
Net transaction value: +$28,796
SEC form: 4
Accepted by SEC: 25 Nov 2025, 16:30:04 UTC
Prior SEC filing: 02 Jul 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro

Key filing fact

Danilo D'Alessandro filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 25 Nov 2025.

Key facts

This page summarizes Danilo D'Alessandro's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Nov 2025, 16:30.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: +$28,796.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001825163 Primary reporting owner

D'Alessandro Danilo

Relationship: Chief Financial Officer
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro
Signature date: 25 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Options Exercise

Transaction value: $28,796
Shares: +3,555
Change %: +5.4%
Price: $8.10
Shares after: 69,923
Date: 21 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value: $0
Shares: -3,555
Change %: -23%
Price: $0.000000
Shares after: 12,082
Date: 21 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,555
Exercise price: $8.10
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.

Footnote F2

The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023.